Genetic screening in cohort of Egyptian patients with pulmonary arterial hypertension disease
Open Access
- 11 February 2025
- journal article
- research article
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 194 (2) , 641-648
Abstract
Background: Variants in the bone morphogenetic protein 2 receptor gene (BMPR2) are the most frequent genetic cause of pulmonary arterial hypertension (PAH). However, correlation of BMPR2 variants and PAH clinical phenotype remains to be elucidated. Methods and results: The goal of the present study is to investigate variants of the causative gene (BMPR2) in 25 Egyptian patients clinically pre-diagnosed with PAH symptoms and 10 healthy candidates using Sanger sequencing technique. Three pathogenic heterozygous missense variants have been illustrated in BMPR2 gene, two novel variants (V387E, E481K) in exon 9 and 11 respectively and one previously reported missense variant (C496G) in exon 11. The remaining 22 patients as well as the 10 healthy individuals showed no pathogenic variants. Conclusion: Further studies on larger number of participants, using advanced NGS technique, should be performed to enrich information about genotype/phenotype correlations and incidence of PAH disease among Egyptian population; thus, it would provide families of PAH patients with accurate genetic counseling in order to prevent disease recurrence.Keywords
Funding Information
- National Research Centre Egypt
This publication has 25 references indexed in Scilit:
- Symptom phenotypes in pulmonary arterial hypertension: The PAH “symptome”Pulmonary Circulation, 2022
- Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association RegistryJournal of the American Heart Association, 2022
- Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 studyPulmonary Circulation, 2022
- Correction to: Management of Pulmonary Arterial HypertensionCurrent Cardiovascular Risk Reports, 2020
- Pulmonary Hypertension: A Brief Guide for CliniciansMayo Clinic Proceedings, 2020
- Structural consequences of BMPR2 kinase domain mutations causing pulmonary arterial hypertensionScientific Reports, 2019
- Effect of Combination Therapy of Endothelin Receptor Antagonist and Phosphodiesterase-5 Inhibitor on Clinical Outcome and Pulmonary Haemodynamics in Patients with Pulmonary Arterial Hypertension: A Meta-AnalysisClinical Drug Investigation, 2019
- A Concerning Trend for Patients With Pulmonary Hypertension in the Era of Evidence-Based MedicineCirculation, 2019
- Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an updateEuropean Respiratory Journal, 2019
- Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic DefectsHuman Mutation, 2015